Asceneuron Investors

16 investors on Angel Roster list Asceneuron in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in France, the Netherlands and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name Asceneuron can appear together.

Investors listed
16
With verified email
44%
Most common stage
Seed
Top location
France

Updated October 13, 2026 · How we compile this data

Top 16 Asceneuron investors

The most complete profiles first. Showing 16 of 16.

  • Noga YerushalmiVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Owen LozmanVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Javier RodriguezVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Matthew FoyVerified

    Corporate Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more

    Verified email available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Cheryl Zimberlin

    Venture Capital, Corporate Venture Capital, Investor · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Christian Patze

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    SeedHealth CareDeepTechConsumer GoodsInfrastructure

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Julian Schubert

    Venture Capital, Corporate Venture Capital · Germany

    Health CareConsumer GoodsInfrastructureChemical

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Peter Neubeck

    Venture Capital, Private Equity Firm · Germany

    Health CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Wallace Wallace

    Venture Capital, Corporate Venture Capital · Netherlands

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Henrijette Richter

    Venture Capital, Private Equity Firm, Investor · Denmark

    SeedBiotechnologyClean TechnologyHealth and Hospital ServicesFinTech

    Portfolio: Twentyeight-Seven Therapeutics, Asceneuron, Nitrase Therapeutics, Mozart Therapeutics

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Asceneuron investors are on Angel Roster?

Angel Roster lists 16 Asceneuron investors. 7 of them (44%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (15), Private Equity Firms (10) and Corporate Venture Capital Firms (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Asceneuron investors invest in?

Among those that list a stage, the most common are Seed (11).

Where are Asceneuron investors based?

Most are based in France (5), the Netherlands (4) and Germany (4).

Which companies have Asceneuron investors backed?

The most-backed portfolio companies among them are DNA Script (14), Translate Bio (8), F-star Biotechnology (8), Progyny (8) and Bird Rock Bio (8).

How do I contact Asceneuron investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.